14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $7.26 $9.72 Friday, 3rd May 2024 VYGR stock ended at $8.81. This is 3.28% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.60% from a day low at $8.61 to a day high of $8.92.
90 days $7.08 $10.66
52 weeks $6.06 $14.34

Historical Voyager Therapeutics prices

Date Open High Low Close Volume
May 03, 2024 $8.76 $8.92 $8.61 $8.81 453 367
May 02, 2024 $8.65 $8.65 $8.27 $8.53 428 588
May 01, 2024 $7.80 $8.55 $7.80 $8.36 606 111
Apr 30, 2024 $7.73 $7.86 $7.63 $7.82 494 552
Apr 29, 2024 $7.68 $7.93 $7.68 $7.77 401 286
Apr 26, 2024 $7.40 $7.71 $7.32 $7.62 342 440
Apr 25, 2024 $7.38 $7.52 $7.26 $7.42 520 769
Apr 24, 2024 $7.65 $7.66 $7.45 $7.57 306 007
Apr 23, 2024 $7.60 $7.78 $7.57 $7.65 366 047
Apr 22, 2024 $7.56 $7.68 $7.47 $7.57 316 453
Apr 19, 2024 $7.50 $7.66 $7.28 $7.50 515 921
Apr 18, 2024 $7.74 $7.88 $7.51 $7.55 1 000 575
Apr 17, 2024 $8.04 $8.04 $7.70 $7.74 765 923
Apr 16, 2024 $8.38 $8.39 $7.95 $7.98 393 452
Apr 15, 2024 $8.36 $8.45 $8.13 $8.24 444 113
Apr 12, 2024 $8.73 $8.84 $8.39 $8.43 548 904
Apr 11, 2024 $8.90 $9.02 $8.76 $8.78 327 903
Apr 10, 2024 $8.90 $8.97 $8.70 $8.83 514 003
Apr 09, 2024 $9.09 $9.24 $9.00 $9.09 301 209
Apr 08, 2024 $9.41 $9.41 $9.04 $9.06 328 374
Apr 05, 2024 $9.15 $9.34 $8.98 $9.33 475 405
Apr 04, 2024 $9.40 $9.66 $9.12 $9.13 687 313
Apr 03, 2024 $9.63 $9.72 $9.25 $9.35 785 905
Apr 02, 2024 $10.31 $10.31 $9.68 $9.91 692 313
Apr 01, 2024 $9.56 $10.66 $9.43 $10.54 1 398 691
Click to get the best stock tips daily for free!

About Voyager Therapeutics

Voyager Therapeutics Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; and Tau... VYGR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT